Ninlaro and Azithromycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ninlaro (ixazomib citrate) and Azithromycin (azithromycin). Common drug interactions include rash among females and neuropathy peripheral among males.

The phase IV clinical study analyzes what interactions people have when they take Ninlaro and Azithromycin. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Ninlaro?

Ninlaro has active ingredients of ixazomib citrate. eHealthMe is studying from 19,563 Ninlaro users. Check the latest studies of Ninlaro.

What is Azithromycin?

Azithromycin has active ingredients of azithromycin. It is often used in sinusitis. eHealthMe is studying from 40,716 Azithromycin users. Check the latest studies of Azithromycin.

On Jul, 29, 2026

31 people who take Ninlaro and Azithromycin together, and have interactions are studied.

Ninlaro and Azithromycin drug interactions.

What are the common drug interactions of Ninlaro and Azithromycin, by gender? *:

female:

Rash
Cataract (clouding of the lens inside the eye)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dementia (madness)
Erythema (redness of the skin)
Eye irritation
Eye swelling
Lacrimation increased
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
Ocular hyperaemia (an abnormally large amount of blood in eye)

male:

Neuropathy peripheral (surface nerve damage)
Sinus disorder (disease of sinus)
Hypoxia (low oxygen in tissues)
Creatinine renal clearance decreased
Skin lesion
Glaucoma (increased fluid pressure in the eye with vision loss)
Pneumonia
Prostate cancer
Rash

What are the common drug interactions of Ninlaro and Azithromycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Prostate cancer
Rash

60+:

Plasma cell myeloma (cancer that begins in plasma cells)
Neuropathy peripheral (surface nerve damage)
Bladder spasm
Blood immunoglobulin g decreased
Blood pressure increased
Constipation
Disease progression
Drug ineffective
Immune system disorder
Increased upper airway secretion

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 22 people, 70.97%
Secondary Immunodeficiency (lack of immunity due to some disease): 5 people, 16.13%
Anaemia (lack of blood): 5 people, 16.13%
Laxative Supportive Care: 3 people, 9.68%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 6.45%
Neutrophil Count Abnormal (abnormal number of neutrophil a type of blood cell): 2 people, 6.45%
Nasopharyngitis (inflammation of the nasopharynx): 2 people, 6.45%
Ill-Defined Disorder: 2 people, 6.45%
Fever: 2 people, 6.45%
Eye Disorder: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Ninlaro and Azithromycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously